near significanceP =0.08
Survival analysis of the CTD‐PAH sub‐cohort showed decreased survival time among those with MB Ees/Ea <0.65, with near significance (HR, 3.3, P =0.08) ( Figure S3B ).
Survival analysis of the CTD‐PAH sub‐cohort showed decreased survival time among those with MB Ees/Ea <0.65, with near significance (HR, 3.3, P =0.08) ( Figure S3B ).